Marlene Gyldmark

Director/Board Member at International Society for Pharmacoeconomics & Outcomes Rsch

Consumer Services

Commercial Services

Profile

Marlene Gyldmark is currently the Director at the International Society for Pharmacoeconomics & Outcomes Research.
She has a graduate degree from York University and another graduate degree from the University of Copenhagen.

Marlene Gyldmark active positions

Companies	Position	Start
International Society for Pharmacoeconomics & Outcomes Rsch International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries.	Director/Board Member	-

All active positions of Marlene Gyldmark

Training of Marlene Gyldmark

University of Copenhagen	Graduate Degree
York University	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Marlene Gyldmark's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
International Society for Pharmacoeconomics & Outcomes Rsch International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries.	Commercial Services